Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

  • There is currently no data for AGR

Director/PDMR Shareholding

6 Aug 2025 12:00

RNS Number : 2387U
Assura PLC
06 August 2025
Ā 

6 August 2025

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 5 August 2025 the following named PDMRs acquired partnership shares and were awarded matching shares over ordinary shares of 10 pence each in the Company under the Company's Share Incentive Plan ("SIP").

PDMR

Position

Number of partnership shares acquired

Number of matching shares awarded

Shareholding of PDMR and PCAs post acquisition and award

Jonathan Murphy

CEO

306

357

3,518,426

Jayne Cottam

CFO

306

357

1,067,285

Orla Ball

General Counsel

306

357

47,723

Robert James

Group Development Director

303

353

38,323

Sarah Taylor

Chief People Officer

303

353

26,824

Steven Noble

Chief Investment Officer

303

354

612,752

Ā 

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Ā 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

Ā 

a)

Name

Ā 

Jonathan Murphy

2

Reason for the notification

Ā 

a)

Position/status

Ā 

CEO

b)

Initial notification/ Amendment

Ā 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Name

Ā 

Assura plc

b)

LEI

Ā 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Description of the financial instrument, type of instrument

Ā 

Identification code

Ordinary shares of 10 pence each

Ā 

Ā 

Ā 

Ā 

Ā 

GB00BVGBWW93

b)

Nature of the transaction

Ā 

Ā 

Acquisition of partnership shares and award of matching shares under the SIP

Ā 

Ā 

Ā 

c)

Price(s) and volume(s)

Ā 

Ā 

Price(s)

Volume(s)

Ā 

Ā£0.493866 GBP

Ā 

Ā 

663

Ā 

Ā 

d)

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

Ā 

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā 

Ā£0.493866 GBP

Ā 

Ā 

663

Ā 

Ā£327.43 GBP

e)

Date of the transaction

Ā 

5 August 2025

f)

Place of the transaction

Ā 

XLON

Ā 

Ā 

Ā 

1

Details of the person discharging managerial responsibilities/person closely associated

Ā 

a)

Name

Ā 

Jayne Cottam

2

Reason for the notification

Ā 

a)

Position/status

Ā 

CFO

b)

Initial notification/ Amendment

Ā 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Name

Ā 

Assura plc

b)

LEI

Ā 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Description of the financial instrument, type of instrument

Ā 

Identification code

Ordinary shares of 10 pence each

Ā 

Ā 

Ā 

Ā 

Ā 

GB00BVGBWW93

b)

Nature of the transaction

Ā 

Ā 

Acquisition of partnership shares and award of matching shares under the SIP

Ā 

Ā 

c)

Price(s) and volume(s)

Ā 

Ā 

Price(s)

Volume(s)

Ā 

Ā£0.493866 GBP

Ā 

Ā 

663

Ā 

Ā 

d)

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

Ā 

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā 

Ā£0.493866 GBP

Ā 

Ā 

663

Ā 

Ā£327.43 GBP

e)

Date of the transaction

Ā 

5 August 2025

f)

Place of the transaction

Ā 

XLON

Ā 

1

Details of the person discharging managerial responsibilities/person closely associated

Ā 

a)

Name

Ā 

Orla Ball

2

Reason for the notification

Ā 

a)

Position/status

Ā 

General Counsel

b)

Initial notification/ Amendment

Ā 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Name

Ā 

Assura plc

b)

LEI

Ā 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Description of the financial instrument, type of instrument

Ā 

Identification code

Ordinary shares of 10 pence each

Ā 

Ā 

Ā 

Ā 

Ā 

GB00BVGBWW93

b)

Nature of the transaction

Ā 

Ā 

Acquisition of partnership shares and award of matching shares under the SIP

Ā 

Ā 

Ā 

c)

Price(s) and volume(s)

Ā 

Ā 

Price(s)

Volume(s)

Ā 

Ā£0.493866 GBP

Ā 

Ā 

663

Ā 

Ā 

d)

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

Ā 

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā 

Ā£0.493866 GBP

Ā 

Ā 

663

Ā 

Ā£327.43 GBP

e)

Date of the transaction

Ā 

5 August 2025

f)

Place of the transaction

Ā 

XLON

Ā 

Ā 

1

Details of the person discharging managerial responsibilities/person closely associated

Ā 

a)

Name

Ā 

Robert James

2

Reason for the notification

Ā 

a)

Position/status

Ā 

Group Development Director

b)

Initial notification/ Amendment

Ā 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Name

Ā 

Assura plc

b)

LEI

Ā 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Description of the financial instrument, type of instrument

Ā 

Identification code

Ordinary shares of 10 pence each

Ā 

Ā 

Ā 

Ā 

Ā 

GB00BVGBWW93

b)

Nature of the transaction

Ā 

Ā 

Acquisition of partnership shares and award of matching shares under the SIP

Ā 

Ā 

Ā 

Ā 

c)

Price(s) and volume(s)

Ā 

Ā 

Price(s)

Volume(s)

Ā 

Ā£0.493866 GBP

Ā 

Ā 

656

Ā 

Ā 

d)

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

Ā 

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā 

Ā£0.493866 GBP

Ā 

Ā 

656

Ā 

Ā£323.98 GBP

e)

Date of the transaction

Ā 

5 August 2025

f)

Place of the transaction

Ā 

XLON

Ā 

1

Details of the person discharging managerial responsibilities/person closely associated

Ā 

a)

Name

Ā 

Sarah Taylor

2

Reason for the notification

Ā 

a)

Position/status

Ā 

Chief People Officer

b)

Initial notification/ Amendment

Ā 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Name

Ā 

Assura plc

b)

LEI

Ā 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Description of the financial instrument, type of instrument

Ā 

Identification code

Ordinary shares of 10 pence each

Ā 

Ā 

Ā 

Ā 

Ā 

GB00BVGBWW93

b)

Nature of the transaction

Ā 

Ā 

Acquisition of partnership shares and award of matching shares under the SIP

Ā 

Ā 

Ā 

Ā 

c)

Price(s) and volume(s)

Ā 

Ā 

Price(s)

Volume(s)

Ā 

Ā£0.493866 GBP

Ā 

Ā 

656

Ā 

Ā 

d)

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

Ā 

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā 

Ā£0.493866 GBP

Ā 

Ā 

656

Ā 

Ā£323.98 GBP

e)

Date of the transaction

Ā 

5 August 2025

f)

Place of the transaction

Ā 

XLON

1

Details of the person discharging managerial responsibilities/person closely associated

Ā 

a)

Name

Ā 

Steven Noble

2

Reason for the notification

Ā 

a)

Position/status

Ā 

Chief Investment Officer

b)

Initial notification/ Amendment

Ā 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Name

Ā 

Assura plc

b)

LEI

Ā 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Description of the financial instrument, type of instrument

Ā 

Identification code

Ordinary shares of 10 pence each

Ā 

Ā 

Ā 

Ā 

Ā 

GB00BVGBWW93

b)

Nature of the transaction

Ā 

Ā 

Acquisition of partnership shares and award of matching shares under the SIP

Ā 

Ā 

Ā 

Ā 

c)

Price(s) and volume(s)

Ā 

Ā 

Price(s)

Volume(s)

Ā 

Ā£0.493866 GBP

Ā 

Ā 

657

Ā 

Ā 

d)

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

Ā 

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā 

Ā£0.493866 GBP

Ā 

Ā 

657

Ā 

Ā£324.47 GBP

e)

Date of the transaction

Ā 

5 August 2025

f)

Place of the transaction

Ā 

XLON

Ā 

For more information, please contact:

Ā 

Assura plc

Ā 

Tel: 0161 515 2043

David Purcell, Investor Relations Director

Ā 

Email: Investor@assura.co.uk

FGS Global

Gordon Simpson

Tel: 0207 251 3801

Email: Assura-LON@fgsglobal.com

Ā 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange.

At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
DSHBGGDIBDGDGUL
Date   Source Headline
18th Jul 20253:30 pmRNSForm 8.3 - AGR LN
18th Jul 20253:25 pmRNSForm 8.3 - Primary Health Properties plc
18th Jul 20253:25 pmBUSForm 8.3 - Assura plc
18th Jul 20253:25 pmRNSForm 8.3 - Assura plc
18th Jul 20253:20 pmRNSForm 8.3 - Assura plc
18th Jul 20253:09 pmRNSForm 8.3 - Primary Health Properties Plc
18th Jul 20253:04 pmRNSForm 8.3 - Assura Plc
18th Jul 20253:00 pmBUSForm 8.3 - ASSURA PLC
18th Jul 20253:00 pmRNSForm 8.3 - Assura PLC
18th Jul 20252:28 pmGNWForm 8.3 - Assura Plc
18th Jul 20252:24 pmRNSForm 8.3 - Primary Health Properties Plc
18th Jul 20252:00 pmBUSForm 8.3 - Assura PLC
18th Jul 20251:44 pmEQSForm 8.3 - The Vanguard Group, Inc.: Assura plc
18th Jul 20251:32 pmRNSForm 8.3 - Assura PLC
18th Jul 20251:22 pmRNSForm 8.3 - Primary Health Properties plc
18th Jul 20251:17 pmRNSForm 8.3 - Assura plc
18th Jul 20251:14 pmRNSForm 8.3 - Assura PLC
18th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Assura Plc
18th Jul 202511:48 amRNSForm 8.3 - Assura Plc
18th Jul 202511:41 amRNSForm 8.3 - Assura plc
18th Jul 202511:27 amRNSForm 8.5 EPT/Non RI ASSURA PLC
18th Jul 202511:25 amRNSForm 8.3 - Assura plc
18th Jul 202511:01 amRNSForm 8.5 (EPT/RI) - Assura plc
18th Jul 202510:13 amRNSForm 8.5 (EPT/NON-RI) Assura Plc
18th Jul 20259:24 amRNSForm 8.5 (EPT/RI)
18th Jul 20257:00 amRNSAdditional Listing & Rule 2.9 Disclosure
17th Jul 20253:25 pmBUSForm 8.3 - Assura plc
17th Jul 20253:25 pmRNSForm 8.3 - Assura plc
17th Jul 20253:25 pmRNSForm 8.3 - Primary Health Properties plc
17th Jul 20253:23 pmGNWForm 8.3 - Assura Plc
17th Jul 20253:20 pmRNSForm 8.3 - Assura plc
17th Jul 20253:13 pmRNSForm 8.3 - Primary Health Properties plc
17th Jul 20253:00 pmRNSForm 8.3 - Assura PLC
17th Jul 20253:00 pmBUSForm 8.3 - ASSURA PLC
17th Jul 20252:51 pmRNSForm 8.3 - Assura plc
17th Jul 20252:49 pmEQSForm 8.3 - The Vanguard Group, Inc.: Assura plc
17th Jul 20252:21 pmRNSForm 8.3 - Primary Health Properties plc
17th Jul 20252:14 pmRNSForm 8.3 - Primary Health Properties plc
17th Jul 20252:14 pmRNSForm 8.3 - Assura plc
17th Jul 20252:03 pmRNSForm 8.5 EPT/Non RI ASSURA PLC
17th Jul 20252:00 pmBUSForm 8.3 - Assura PLC
17th Jul 20251:18 pmRNSForm 8.3 - Assura Plc
17th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Assura Plc
17th Jul 202511:43 amRNSForm 8.3 - Assura plc
17th Jul 202510:36 amRNSForm 8.5 (EPT/RI) - Assura plc
17th Jul 202510:35 amRNSForm 8.3 - Assura PLC
17th Jul 20259:28 amRNSForm 8.5 (EPT/RI)
16th Jul 20253:30 pmRNSForm 8.3 - PHP LN
16th Jul 20253:30 pmRNSForm 8.3 - AGR LN
16th Jul 20253:29 pmRNSForm 8.3 - Assura plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.